It is estimated that the world population will reach a record 7.3 billion in 2015, and the high
burden of chronic conditions associated with ageing and smoking will increase further …

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive
Pulmonary Disease | NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) …

Background The role of oral corticosteroids in treating patients with exacerbations of chronic
obstructive pulmonary disease (COPD) remains contentious. We assessed in a prospective …

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality
worldwide and results in an economic and social burden that is both substantial and …

Exacerbations of COPD are thought to be caused by interactions between host factors,
bacteria, viruses, and changes in air quality to produce increased inflammation in the lower …

Purpose: To review critically the available data on diagnostic evaluation, risk stratification,
and therapeutic management of patients with acute exacerbations of chronic obstructive …

Study objectives To critically review the available data on the diagnostic evaluation, risk
stratification, and therapeutic management of patients with acute exacerbations of COPD …

Chronic Obstructive Pulmonary Disease (COPD) is a major public health problem. It is the
fourth leading cause of chronic morbidity and mortality in the United States (1) and is …

Los límites aquí propuestos son arbitrarios y tienen un carácter empírico, dado que no
existen evidencias que los apoyen, aunque se corresponden con los establecidos por otras …

Chronic obstructive pulmonary disease (COPD) is a major cause of disability, hospital
admission and premature death. More than half a million Australians are estimated to have …